Search in biosurfit Start writing...

how a real problem became an everyday solution.

biosurfit is a Portuguese diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology. 
biosurfit developed the spinit® technology, the first and only, diagnostics system capable of performing the major PoC blood test modalities (haematology, immunoassays and clinical chemistry) on the same instrument.


At biosurfit we work every day to shape the future of in-vitro diagnostic testing. 

We want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients.


At biosurfit, our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. 
Our best assets are Innovative, Excellent, Responsible and Fair.

biosurfit guides its activities under an impeccable and socially responsible code of ethical conduct. This can be seen in all our internal and external relationships with employees, shareholders, customers, suppliers, universities and partners, public entities, official entities, press or public. biosurfit´s ethical conduct is practised daily by all of its’ employees while performing their daily activities.

our track record

2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
biosurfit wins ANJE (Associação Nacional de Jovens Empresários) entrepreneur of the year
biosurfit receives ISO9001: 2008 & ISO13485:2004 certification from TÜV Rheinland
biosurfit wins “Hospital do Futuro” award
biosurfit receives the results of the “Point of care medical test market research”, project delivered by IMS Healthcare
biosurfit wins the “Growth Companies Competition” in the HiTBarcelona -World Innovation Summit.
Semi-automated production line validated
biosurfit gets CE Marking of the spinit® instrument and the first test, spinit® CRP for quantitative measurement of C-Reactive Protein in blood
biosurfit wins Start-up of the Year award from Portugal Ventures
biosurfit was present at MEDICA, the world’s largest Medicine Forum, for the first time as an exhibitor
June: first distribution agreement signed with Rev Diagnostics, The Netherlands
Awarded €1.4m grant by the European Commission’s 7th Framework Programme
May: biosurfit receives CE Mark for spinit® Blood Count test
February: biosurfit’ s first commercial sale in the Netherlands
biosurfit secures €12 million loan from the European Investment Bank
biosurfit wins “Live Sciences & Med Tech Venture of the Year” from Portugal Ventures
biosurfit secures €4.3 of public funding from the European Union program PT2020
biosurfit receives CE mark for the spinit® HbA1c test
Several distribution contracts signed in Europe
spinit® launched in 13 different countries
IFCC and NGSP certification for spinit® HbA1c
biosurfit wins award of distinction “BORN FROM KNOWLEDGE” at the 14th National Meeting of Innovation COTEC-ANI
new manufacturing facility in Azambuja
biosurfit achieves a significant commercial milestone - 500 spinit® Instruments placed with European Customers
New website launch
biosurfit receives Innovation Award at the first edition of the EIB Venture Debt Summit
biosurfit signs strategic Partnership - €10 million of equity financing from Boule Diagnostics and 200M co-investment fund
biosurfit launches new sample collection method | spinit® strip
Launch of spinit® CRP and spinit® HbA1c controls solution.


We are a young, dynamic and diverse team of people from different backgrounds from PhD’s, engineers, biotechnology, IT, management, commercial and financial, marketing and production who work every day with the same purpose. 

We are committed in making a difference in the medical diagnostics industry, helping people to achieve a better quality of life so they can enjoy it the best possible way. 

management team

Chief Executive Officer

João Garcia da Fonseca

  • Founder and CEO of biosurfit (2006); 
  • Strong scientific background, multiple publications in top peer-reviewed journals of applied physics, author of more than 21 patents related to the spinit® technology; 
  • Recognised for his work with various awards, notably Portuguese Young Entrepreneur of the Year in 2007; 
  • Previously founder and CEO of LCT, a start-up company developing technologies for bi-stable liquid crystal displays; 
  • PhD in Physics Engineering, Louis Pasteur University, Strasbourg; Degree in Physics Engineering from Technical University of Lisbon. 


Ian Gilham, PhD

  • Chairman of biosurfit since March 2013; 
  • 30+ year healthcare industry career encompassing all aspects of company growth and development - significant expertise in the fields of pharmaceuticals and clinical diagnostics; 
  • Formerly CEO of LSE-listed IVD company, Axis-Shield plc, a world-leader in Point of Care Testing -sold to Alere in 2011 for £235m. Senior general management, marketing, BD and R&D positions with GSK, Abbott, Celltech & Amersham; 
  • Currently non-executive Chairman of AIM-listed Genedrive plc (UK), Horizon Discovery Group plc (UK) and Multiplicom NV (NL).

Chief Marketing Officer

Daniel Neves, MBA

  • CMO since 2009;
  • 7+ years in the PoC diagnostic industry; 15+ years of experience in general management, finance, fund raising, business development and marketing;
  • Formerly General Manager of forum B2B; several key senior positions in the management team of Logica South America (Logica plc, UK). Management consultancy work in sectors such as Utilities, Telecom and Healthcare;
  • International MBA from IE Business School (Dean’s class) and a science degree in Applied Mathematics from the University of Lisbon. 

Failed to load the Page Fonts We apologize, but the user experience may not be the best! Got it